Guru Ownership Trend
Guru Analysis for First Tracks Biotherapeutics, Inc. (TRAX)
First Tracks Biotherapeutics, Inc. (TRAX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $21.52 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $9.83 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for First Tracks Biotherapeutics, Inc. (TRAX)
Major holders include Steven Cohen ($8.22 M), Ken Fisher ($1.04 M), Cliff Asness ($579,696). According to the latest reported data, 3 tracked investment managers collectively hold approximately 488,691 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.83 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in TRAX during the most recent reporting period.
Yes, 3 managers opened new positions in TRAX, and 0 increased their existing holdings. The total reported buy value was $9.83 M.